FDA Panel Supports Cymbalta for Chronic Pain
Links shared publicly online about this topic.
- 935total visits
FDA Panel Supports Cymbalta for Chronic Pain
View full resource at webmd.com
Tags: Chronic Pain, Anxiety Medication, Antidepressant, Fibromyalgia Medication, Neuropathic Pain Medication, FDA, Cymbalta
Most Recently Shared on August 20, 2010 at 12:25 am By:
FDA Panel Supports Cymbalta for Chronic Pain: An FDA advisory panel gave a closely divided vote of support to drug... http://bit.ly/atC2PJ
Also Shared By:
FDA Advisory Panel Recommends Cymbalta for Use to Treat Chronic Pain
spine-health.com — “Read what conditions the FDA advisory panel recommends for Cymbalta to treat.” View full resource at spine-health.com
Most Recently Shared on August 26, 2010 at 12:57 am By:
FDA Advisory Panel Recommends Cymbalta for Use to Treat Chronic Pain http://bit.ly/cuD8sU
Cymbalta: FDA panel gives a qualified nod to antidepressant for chronic pain - latimes.com
latimes.com — “A government advisory panel says the FDA should allow marketing of the antidepressant Cymbalta for a wider range of pain, including chronic back pain.” View full resource at latimes.com
Most Recently Shared on August 21, 2010 at 6:49 pm By:
JillofAllTrades,MD Doctor, Family Medicine Doctor, and Physician
FDA panel gives a qualified nod to antidepressant for chronic pain - http://bit.ly/ca8sQ7 << to "include those with chronic back pain"
Cymbalta Nears Approval for Use on Chronic Pain - NYTimes.com
nytimes.com — “An advisory panel to the Food and Drug Administration voted 8-6 to expand approved uses of Cymbalta.” View full resource at nytimes.com
Most Recently Shared on August 20, 2010 at 11:02 pm By:
Eli Lilly closer to getting Cymbalta approved to help with chronic pain. FDA in favor with 8-6 vote. http://dld.bz/s9Ex
UPDATE 2-FDA panel backs wider use of Eli Lilly's Cymbalta | Reuters
reuters.com — “* Eli Lilly's Cymbalta OK'd for chronic pain -FDA panel * Panelists split over back pain, arthritis use * Drugmaker seeking FDA approval to promote new use * FDA deadline passed, decision could come” View full resource at reuters.com
Most Recently Shared on August 20, 2010 at 3:59 pm By:
Women In Pain Health Organization
FDA panel supports Cymbalta for back pain, but not osteoarthritis http://www.reuters.com/article/idUSN1925181020100819 http://fb.me/FZGJbQkQ
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications - QualityPoint Technologies
qualitypointtech.net — “The Anesthetic and Life Support Drugs Advisory Committee which advises the FDA on whether to approve new drugs or alter their indications, has voted 8-6 in favor of expanding pain indications for Cymbalta (duloxetine HCl). The Committee's decision is not final - the FDA has to decide - however, the FDA usually goes along with what the Committee recommends. The Advisory Committee recommended the expanded use of Cymbalta for the treatment of chronic knee and lower back pain...” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2010 at 1:18 pm By:
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications: The Anesthetic and Lif... http://bit.ly/cEcF29
News: FDA panel backs wider use of Eli Lilly's Cymbalta in chronic pain http://bit.ly/beWoNf - #health
reuters.com — “News: FDA panel backs wider use of Eli Lilly's Cymbalta in chronic pain http://bit.ly/beWoNf - #health” View full resource at reuters.com
Most Recently Shared on August 20, 2010 at 12:45 am By:
Hisham Rana, MD Physician and Doctor
News: FDA panel backs wider use of Eli Lilly's Cymbalta in chronic pain http://bit.ly/beWoNf - #health
Lilly wins panel's backing to expand Cymbalta use | Indianapolis Business Journal | IBJ.com
ibj.com — “Eli Lilly and Co., the drugmaker whose top three products face generic competition within three years, won a U.S. panel’s backing to expand use of the antidepressant Cymbalta in chronic knee and back pain. Outside advisers to the Food and Drug Administration voted 8-6 Thursday in Bethesda, Md., in favor of a broader use of Cymbalta on the basis of studies in lower back pain and osteoarthritis of the knee. The FDA usually follows its panels’ recommendations, though it isn’t requ” View full resource at ibj.com
Most Recently Shared on August 19, 2010 at 11:10 pm By:
Lilly gains panel's backing to expand Cymbalta use: Outside advisers to the Food and Drug Administration voted 8-6... http://bit.ly/9wdbD0
Equivocal Message on Duloxetine for Pain from Panel - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- BETHESDA, Md. " An FDA advisory committee has voted narrowly " 8 to 6 " to recommend that the agency expand the indication for the antidepressant duloxetine (Cymbalta) to treat chronic musculoskeletal pain.” View full resource at qualitypointtech.net
Most Recently Shared on August 19, 2010 at 10:45 pm By:
Equivocal Message on Duloxetine for Pain from Panel: (MedPage Today) -- BETHESDA, Md. — An FDA advisory committe... http://bit.ly/bD6tYP
F.D.A. Panel Approves Use of Antidepressant for Pain - QualityPoint Technologies
qualitypointtech.net — “An advisory committee votes to allow Eli Lilly to market Cymbalta for chronic pain, especially back ailments. (Source: NYT Health)” View full resource at qualitypointtech.net
Most Recently Shared on August 19, 2010 at 9:30 pm By:
F.D.A. Panel Approves Use of Antidepressant for Pain: An advisory committee votes to allow Eli Lilly to market Cym... http://bit.ly/bMBGWP
F.D.A. Panel Approves Use of Antidepressant for Pain - Prescriptions Blog - NYTimes.com
prescriptions.blogs.nytimes.com — “An advisory committee votes to allow Eli Lilly to market Cymbalta for chronic pain, especially back ailments.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on August 19, 2010 at 8:08 pm By:
F.D.A. Panel Approves Use of Antidepressant for Pain: An advisory committee votes to allow Eli Lilly to market Cym... http://bit.ly/9CcLIO
Medical News: FDA Panel to Consider Pain Indication for Antidepressant - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- An FDA advisory committee will meet later this week to review whether the antidepressant duloxetine (Cymbalta) should be used as a treatment for chronic pain despite risks that include l” View full resource at medpagetoday.com
Most Recently Shared on August 18, 2010 at 1:59 pm By:
UIC_Doc - Dr Roy Settergren Doctor, CAM, Chiropractor, and Active Health Library
News: FDA Panel to Consider Chronic Pain Indication for Antidepressant Cymbalta http://t.co/nFpwuwB
Medical News: FDA Panel to Consider Pain Indication for Antidepressant - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- An FDA advisory committee will meet later this week to review whether the antidepressant duloxetine (Cymbalta) should be used as a treatment for chronic pain despite risks that include l” View full resource at medpagetoday.com
Most Recently Shared on August 17, 2010 at 9:23 pm By:
Patricia Grace Eldercare Expert
FDA Panel to Consider Pain Indication for Antidepressant: WASHINGTON (MedPage Today) -- An FDA advisory committee ... http://bit.ly/cndgtP
Medical News: FDA Panel to Consider Pain Indication for Antidepressant - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- An FDA advisory committee will meet later this week to review whether the antidepressant duloxetine (Cymbalta) should be used as a treatment for chronic pain despite risks that include l” View full resource at medpagetoday.com
Most Recently Shared on August 17, 2010 at 8:50 pm By:
FDA Panel to consider pain indication for antidepressant: http://bit.ly/cKm4qw
FDAAdvisoryCommittee.com to Webcast Review of Cymbalta(R) as Treatment for Chronic Pain
marketwire.com — “FDAAdvisoryCommittee.com (FDAAC.com), a provider of live video webcasts of Food and Drug Administration (FDA) Advisory Committee meetings, today announced that it will webcast the meeting of the Anesthetic and Life Support Drugs Advisory Committee as it discusses Cymbalta as treatment of chronic pain. The meeting is scheduled to occur on August 19, 2010 from 8:00 a.m. to 4:30 p.m. ET. On the heels of recently” View full resource at marketwire.com
Most Recently Shared on August 17, 2010 at 4:57 pm By:
FDAAdvisoryCommittee.com to Webcast Review of Cymbalta(R) as Treatment for Chronic Pain: Meeting to Discuss New Us... http://bit.ly/9Z6Bw6
Advertisement
Heart Health
@HeartsHealth
webMD: FDA Panel Supports Cymbalta for Chronic Pain http://bit.ly/9bfyNN Full http://bit.ly/cwUeLw
1 year ago...